Abstract
A new screening approach for anticancer active compounds is presented. In this method, a target enzyme is incubated with a mixture of compounds, and then the complex formed by the target and small molecules is separated from the rest of the mixture by ultra-filtration. The complex that is retained on the membrane is subsequently washed with acid and small molecules that are specifically bound to the target are released and collected, then analyzed by highperformance liquid Chromatograph combined with electrospray ionization mass spectrometry (HPLC/ESI-MS) analysis. We have successfully applied this method to screen anticancer compounds. DNA topoisomerase II is used as a target to capture anti-tumor candidates from a mixture of combinatorial compounds, such as doxorubicin, daunorubicin and pravastain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Terrett, N. K., Gardner, M., Gordon, D. W. et al., Combinatorial synthesis—The design of compound libraries and their application to drug discovery, Tetrahedron, 1995, 51: 8135–8173.
Gordon, E. M., Gallop, M. A., Campbell, D. et al., Combinatorial organic synthesis: Applications to drug discovery, Eur. J. Med. Chem., 1995, 30: 337s–348s.
Li, Y. Y., Li, Z. Y., Wang, H. et al., Topoisomerases and anticancer drugs, Pharmaceutical Advance (in Chinese), 1996, 20(3): 138–142.
Nicholas, R. C., DNA gyrase and the supercoiling of DNA, Science, 1980, 207: 953.
Lock, R. B., Ross, W. E., DNA topoisomerases in cancer therapy, Anti-cancer drug design, 1987, 2: 151–154.
Liu, C. C., Xie, B. F., Pan, Q. C., The relationship of DNA intercalative agents and inhibitors of DNA topoisomerase II and antitumor—Introducing two methods for antitumor drug screening, Cancer (in Chinese), 1991, 10(3): 215–219.
Liu, X. M., Wang, L. G., Ji, X. J., Determination of DNA topoisomerase II from mouse leukemia L1210 cells as target for screening antitumor agents, Cancer (in Chinese), 1991, 10(3): 220–225.
Wllison-lingard, L., Davis, P. W., Ecker, D. J. et al., Deconvolution of combinatorial libraries for drug discovery: Experimental comparison of pooling strategies, J. Med Chem., 1996, 39: 2720–2726.
Gallop, M. A., Barrett, R. W., Dower, W. J. et al., Applications of combinatorial Technologies to drug discovery, 1. Background and peptide combinatorial Libraries, J. Med. Chem., 1994, 37: 1233–1251.
Eric, G., Zhuang, S., Benjamin, E. et al., Methionine aminopeptidas (type 2) is the common target for angiogensis inhibitors AGM-1470 and ovalicin, Chem. & Biol., 1997, 4(6): 461–771.
Randall, W. N., Jennifer, R. K., Allan, L. B. et al., Mass spectrometric Immunoassay, Anal. Chem., 1995, 67: 1153–1158.
Brummel, C. L., Vickerman, J. C., Carr, S. A. et al., Evaluation of mass spectrometric methods applicable to the direct analysis of non-peptide bead-bound combinatorial libraries, Anal. Chem., 1996, 68: 237–242.
Wu, D. L., Li, M. J., Gao, H. Z. et al., Doxorubicin—albumin conjugate reverses resistance in multidrug resistant KB/VCR cells to daunorubicin, Chinese Journal of Pharmacology and Toxicology, 1997, 11(1): 54–58.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Pan, Y., Zhang, H. & Chen, Y. New approach for screening anti-tumor compounds. Chin.Sci.Bull. 48, 630–633 (2003). https://doi.org/10.1007/BF03325643
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03325643